If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Rows 7 and 9: Dr. Liu has been awarded 39,765 options by the Issuer in consideration for his services as a director of the Company, of which 20,341 are currently vested, 5,327 are unvested but will vest within 60 days of the date hereof, and 14,097 of which are unvested and will not have vested within 60 days of the date hereof.


SCHEDULE 13D


 
Seven Fleet Partners LP
 
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu, Managing Member of Seven Fleet Advisors, LLC, its Investment Manager
Date:09/18/2025
 
Seven Fleet Advisors LLC
 
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu, Managing Member
Date:09/18/2025
 
Brian Liu
 
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu
Date:09/18/2025